- Helps in controlling blood sugar levels in adults with type 2 diabetes mellitus.
- Reduces the risk of diabetes-related complications when used alongside diet and exercise.
- Improves insulin sensitivity and decreases hepatic glucose production.
- Enhances the body’s ability to lower blood sugar through DPP-4 inhibition.
- Can be used as part of a combination therapy for better glycemic control.
- May help in weight management compared to other diabetes medications.
- Convenient oral tablet formulation for easy administration.
Jalra M 50/500 mg Tablet - Strip of 15
Compositions : Vildagliptin 50mg + Metformin 500mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: USV Private Limited
Recommended Substitute
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Jalra M 50/500 mg Tablet is a pharmaceutical product designed to manage blood sugar levels in patients with type 2 diabetes mellitus. This medication combines two active ingredients: Metformin and Vildagliptin. Metformin is a biguanide that primarily works by decreasing hepatic glucose production and improving insulin sensitivity, while Vildagliptin is a DPP-4 inhibitor that enhances the body's own ability to lower blood sugar levels. The combination of these two agents in Jalra M 50/500 mg Tablet provides a synergistic effect, making it an effective option for patients who require better glycemic control. The formulation is available in tablet form, making it convenient for oral administration. The primary therapeutic purpose of Jalra M 50/500 mg Tablet is to help manage blood glucose levels in adults with type 2 diabetes, particularly when diet and exercise alone do not provide adequate control. It is essential for patients to understand that Jalra M 50/500 mg Tablet should be used as part of a comprehensive diabetes management plan that includes dietary modifications and physical activity. Regular monitoring of blood glucose levels is also crucial to ensure the effectiveness of the treatment and to make any necessary adjustments. Patients should consult their healthcare provider for personalized advice regarding the use of Jalra M 50/500 mg Tablet, including potential benefits, risks, and any necessary lifestyle changes that may enhance the effectiveness of the medication. Overall, Jalra M 50/500 mg Tablet represents a valuable option for individuals seeking to achieve better control over their diabetes management.
Product Details
- Metformin reduces glucose production in the liver and increases insulin sensitivity in peripheral tissues.
- Vildagliptin inhibits the enzyme DPP-4, which leads to increased levels of incretin hormones.
- Increased incretin levels enhance insulin secretion from the pancreas in response to meals.
- Both components work together to lower blood glucose levels effectively.
- The combination helps in reducing postprandial (after meal) blood sugar spikes.
- Take Jalra M 50/500 mg Tablet orally with water.
- The usual starting dose is one tablet taken twice daily, preferably with meals.
- Dosage may be adjusted based on individual blood glucose levels and physician recommendations.
- Do not exceed the prescribed dosage without consulting your healthcare provider.
- Maintain a consistent schedule for taking the medication to optimize its effectiveness.
- If a dose is missed, take it as soon as you remember unless it is close to the time for your next dose.
- Do not double up on doses to make up for a missed one.
- Adopt a balanced diet rich in whole grains, fruits, vegetables, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to track the effectiveness of Jalra M 50/500 mg Tablet.
- Stay hydrated and limit sugary beverages that can spike blood sugar levels.
- Avoid smoking and limit alcohol consumption as they can affect blood sugar control.
Safety Advice
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite.
- Some patients may experience headaches or dizziness.
- Serious side effects can include lactic acidosis, which is a rare but serious condition requiring immediate medical attention.
- If you experience symptoms like unusual tiredness, muscle pain, or difficulty breathing, seek medical help promptly.
- Allergic reactions such as rash, itching, or swelling may occur; discontinue use and consult a doctor if these symptoms arise.
Precautions and Warnings
- Avoid use if you have severe kidney disease or are on dialysis.
- Consult your doctor before using if you have liver problems or heart conditions.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before using Jalra M 50/500 mg Tablet.
- Alcohol consumption should be limited due to potential interactions affecting blood sugar levels.
- Monitor kidney function regularly during treatment as it may affect drug clearance.
- Be cautious when driving or operating machinery until you know how Jalra M 50/500 mg Tablet affects you.
FAQs
Jalra M 50/500 mg Tablet may not be suitable for individuals with certain medical conditions such as severe kidney impairment or those with a history of hypersensitivity to its components.
2. What should I do if I miss a dose of Jalra M 50/500 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
3. Can I take Jalra M 50/500 mg Tablet with other medications?
Always inform your healthcare provider about all medications you are taking, as some drugs may interact with Jalra M 50/500 mg Tablet.
4. How should I store Jalra M 50/500 mg Tablet?
Store Jalra M 50/500 mg Tablet at room temperature away from moisture and heat, and keep it out of reach of children.
5. Can I drink alcohol while taking Jalra M 50/500 mg Tablet?
It is advisable to limit alcohol consumption while taking Jalra M 50/500 mg Tablet, as it can affect blood sugar levels.
6. What are the common side effects of Jalra M 50/500 mg Tablet?
Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, or abdominal pain.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 915028 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | USV Private Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Jalra M 50/500 mg Tablet is a pharmaceutical product designed to manage blood sugar levels in patients with type 2 diabetes mellitus. This medication combines two active ingredients: Metformin and Vildagliptin. Metformin is a biguanide that primarily works by decreasing hepatic glucose production and improving insulin sensitivity, while Vildagliptin is a DPP-4 inhibitor that enhances the body's own ability to lower blood sugar levels. The combination of these two agents in Jalra M 50/500 mg Tablet provides a synergistic effect, making it an effective option for patients who require better glycemic control. The formulation is available in tablet form, making it convenient for oral administration. The primary therapeutic purpose of Jalra M 50/500 mg Tablet is to help manage blood glucose levels in adults with type 2 diabetes, particularly when diet and exercise alone do not provide adequate control. It is essential for patients to understand that Jalra M 50/500 mg Tablet should be used as part of a comprehensive diabetes management plan that includes dietary modifications and physical activity. Regular monitoring of blood glucose levels is also crucial to ensure the effectiveness of the treatment and to make any necessary adjustments. Patients should consult their healthcare provider for personalized advice regarding the use of Jalra M 50/500 mg Tablet, including potential benefits, risks, and any necessary lifestyle changes that may enhance the effectiveness of the medication. Overall, Jalra M 50/500 mg Tablet represents a valuable option for individuals seeking to achieve better control over their diabetes management.
- Helps in controlling blood sugar levels in adults with type 2 diabetes mellitus.
- Reduces the risk of diabetes-related complications when used alongside diet and exercise.
- Improves insulin sensitivity and decreases hepatic glucose production.
- Enhances the body’s ability to lower blood sugar through DPP-4 inhibition.
- Can be used as part of a combination therapy for better glycemic control.
- May help in weight management compared to other diabetes medications.
- Convenient oral tablet formulation for easy administration.
- Metformin reduces glucose production in the liver and increases insulin sensitivity in peripheral tissues.
- Vildagliptin inhibits the enzyme DPP-4, which leads to increased levels of incretin hormones.
- Increased incretin levels enhance insulin secretion from the pancreas in response to meals.
- Both components work together to lower blood glucose levels effectively.
- The combination helps in reducing postprandial (after meal) blood sugar spikes.
- Take Jalra M 50/500 mg Tablet orally with water.
- The usual starting dose is one tablet taken twice daily, preferably with meals.
- Dosage may be adjusted based on individual blood glucose levels and physician recommendations.
- Do not exceed the prescribed dosage without consulting your healthcare provider.
- Maintain a consistent schedule for taking the medication to optimize its effectiveness.
- If a dose is missed, take it as soon as you remember unless it is close to the time for your next dose.
- Do not double up on doses to make up for a missed one.
- Adopt a balanced diet rich in whole grains, fruits, vegetables, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to track the effectiveness of Jalra M 50/500 mg Tablet.
- Stay hydrated and limit sugary beverages that can spike blood sugar levels.
- Avoid smoking and limit alcohol consumption as they can affect blood sugar control.
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite.
- Some patients may experience headaches or dizziness.
- Serious side effects can include lactic acidosis, which is a rare but serious condition requiring immediate medical attention.
- If you experience symptoms like unusual tiredness, muscle pain, or difficulty breathing, seek medical help promptly.
- Allergic reactions such as rash, itching, or swelling may occur; discontinue use and consult a doctor if these symptoms arise.
Precautions and Warnings
- Avoid use if you have severe kidney disease or are on dialysis.
- Consult your doctor before using if you have liver problems or heart conditions.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before using Jalra M 50/500 mg Tablet.
- Alcohol consumption should be limited due to potential interactions affecting blood sugar levels.
- Monitor kidney function regularly during treatment as it may affect drug clearance.
- Be cautious when driving or operating machinery until you know how Jalra M 50/500 mg Tablet affects you.
Jalra M 50/500 mg Tablet may not be suitable for individuals with certain medical conditions such as severe kidney impairment or those with a history of hypersensitivity to its components.
2. What should I do if I miss a dose of Jalra M 50/500 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
3. Can I take Jalra M 50/500 mg Tablet with other medications?
Always inform your healthcare provider about all medications you are taking, as some drugs may interact with Jalra M 50/500 mg Tablet.
4. How should I store Jalra M 50/500 mg Tablet?
Store Jalra M 50/500 mg Tablet at room temperature away from moisture and heat, and keep it out of reach of children.
5. Can I drink alcohol while taking Jalra M 50/500 mg Tablet?
It is advisable to limit alcohol consumption while taking Jalra M 50/500 mg Tablet, as it can affect blood sugar levels.
6. What are the common side effects of Jalra M 50/500 mg Tablet?
Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, or abdominal pain.
Directions for Use
Storage and Disposal
| SKU | 915028 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | USV Private Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account